Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients.

BACKGROUND

Gender-specific differences in the outcome of COVID-19 patients requiring intensive care treatment have been reported. However, a potential association with ICU therapy remains elusive.

METHODS

A total of 224 consecutive patients (63 women) treated for severe COVID-19 disease requiring mechanical ventilation were screened for the study. After propensity score matching for gender, 40 men and 40 women were included in the study. Comparative analysis was conducted for laboratory parameters, ICU therapy and complications (pulmonary embolism, thrombosis, stroke, and ventricular arrhythmias), and outcome (mortality).

RESULTS

Male patients had significantly higher levels of CRP ( = 0.012), interleukin-6 ( = 0.020) and creatinine ( = 0.027), while pH levels ( = 0.014) were significantly lower compared to females. Male patients had longer intubation times ( = 0.017), longer ICU stays ( = 0.022) and higher rates of catecholamine dependence ( = 0.037). Outcome, complications and ICU therapy did not differ significantly between both groups.

CONCLUSION

The present study represents the first matched comparison of male and female COVID-19 patients requiring intensive care treatment. After propensity matching, male patients still displayed a higher disease severity. This was reflected in higher rates of vasopressors, duration of ICU stay and duration of intubation. In contrast, no significant differences were observed in mortality rates, organ replacement therapy and complications during ICU stay.